ZEB2

protein-coding

zinc finger E-box binding homeobox 2, the group of ZF class homeoboxes and pseudogenes|Zinc fingers C2H2-type

Gene summary

The protein encoded by this gene is a member of the Zfh1 family of 2-handed zinc finger/homeodomain proteins. It is located in the nucleus and functions as a DNA-binding transcriptional repressor that interacts with activated SMADs. Mutations in this gene are associated with Hirschsprung disease/Mowat-Wilson syndrome. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jan 2010]

Previous symbols:
  • ZFHX1B

MANE transcript

NM_014795.4

Inheritance

AD

ClinVar variants

P:426U:543B:557

Top phenotype

Mowat-Wilson syndrome

gnomAD constraint

pLI —, LoF o/e 0.02

Max pathogenic AF

—

Genomic locus

chr2:144,364,364-144,521,057

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~156.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Mowat-Wilson syndromeDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0009341

Submitter: ClinGen

*ZEB2* is located on chromosome 2q22.3 and encodes a transcription factor involved in multiple developmental processes. In the nervous system, ZEB2 regulates neuronal specification, migration, and differentiation. *ZEB2* was first reported in relation to autosomal dominant Mowat-Wilson syndrome in 2001 (Wakamatsu et al., PMID: 11279515; Cacheux et al., PMID: 11448942). Mowat-Wilson syndrome is characterized by moderate-to-severe intellectual disability, severe speech impairment, typical facial dysmorphic features, short stature with microcephaly, seizures, and congenital anomalies, including Hirschsprung disease, congenital heart defects, genitourinary abnormalities, and hypoplasia or agenesis of the corpus callosum. Eight variants (4 frameshift, 3 nonsense and 1 missense) that have been reported in eight probands in three publications (PMIDs: 11448942, 16053902, 38351292) are included in this curation. Variants are typically *de novo*. Most patients have truncating variants or gene deletions; pathogenic missense variants are rare and result in a milder clinical presentation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is loss of function. A specific DNA methylation signature can be observed in individuals with pathogenic variants in *ZEB2* (PMID: 38351292). This gene-disease relationship is also supported by mouse models and functional alteration in non-patient cells. In summary, there is definitive evidence supporting the relationship between *ZEB2* and autosomal dominant Mowat-Wilson syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on May 23, 2018. It was reevaluated on July 1, 2026 (SOP Version 12). As a result of this reevaluation, the classification did not change.

Mowat-Wilson syndromeDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0009341

Submitter: Ambry Genetics

Mowat-Wilson syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0009341

Submitter: Labcorp Genetics (formerly Invitae)

Mowat-Wilson syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0009341

Submitter: PanelApp Australia

Mowat-Wilson syndromeDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0009341

Submitter: G2P

Clinical Genomic Database (CGD)

Mowat-Wilson syndromeAD

Manifestation: Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic

Intervention: General

Rationale: The condition can include Hirschsprung disease, among other multi-systemic manifestations; Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 9719364; 11448942; 11279515; 14679597; 15121779; 16088920; 16688751; 16532472; 17203459; 19215041;20301585; 21343952; 21497296; 22246645; 22486326; 23322667; 23427518; 23466526; 23523603; 24029077; 24715670; 27831545Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ZEB2 variants in ClinVar

22 Conditions Cataloged
Mowat-Wilson syndromeTotal: 1292
not providedTotal: 427
Inborn genetic diseasesTotal: 206
not specifiedTotal: 187
ZEB2-related disorderTotal: 90
See casesTotal: 5
Neurodevelopmental disorderTotal: 3
Intellectual disabilityTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_014795.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
8
clinvar
339
clinvar
3
clinvar
350
missense
11
clinvar
36
clinvar
522
clinvar
170
clinvar
45
clinvar
784
nonsense
99
clinvar
17
clinvar
3
clinvar
119
start loss
3
clinvar
3
frameshift
201
clinvar
42
clinvar
5
clinvar
248
splice donor/acceptor (+/-2bp)
12
clinvar
8
clinvar
2
clinvar
22
Total323103543509481526

Highest pathogenic variant AF is 0.0000020521632

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 49 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_014795.4RefSeqNP_055610.19MANE Select
ENST00000627532.3EnsemblENSP00000487174.19MANE Select
NM_001171653.2RefSeqNP_001165124.18Standard
ENST00000303660.8EnsemblENSP00000302501.49Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
zeb2bDanio rerio

Structure: intrahepatic bile duct

Quality: decreased length

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • MicroRNAs in cancer - Homo sapiens (human)
  • TGF-beta Signaling Pathway
  • EMT transition in Colorectal Cancer
  • TGF-beta Receptor Signaling
  • TGF_beta_Receptor

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • neural crest cell migration
  • somitogenesis
  • neural tube closure
  • nervous system development

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription repressor activity, RNA polymerase II-specific
  • DNA-binding transcription activator activity, RNA polymerase II-specific
  • protein binding
  • phosphatase regulator activity

Cellular Component

  • nuclear chromatin
  • nucleus
  • nucleolus
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000558170
Coding exons
9
Length
140500
Individuals with no LoFs
124846
Homozygous LoFs
0
Heterozygous LoFs
1
Defined
124847
p
0.00000400
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense3.943786640.5690.00003778112
Missense (PolyPhen)73211.530.345112608
Synonymous-0.2332642591.020.00001652239
Loss of Function6.03144.30.02260.00000251583

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish0.0000990.000099rare
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)00.0absent
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcriptional inhibitor that binds to DNA sequence 5'- CACCT-3' in different promoters. Represses transcription of E- cadherin. {ECO:0000269|PubMed:16061479}.;
Disease
DISEASE: Mowat-Wilson syndrome (MOWS) [MIM:235730]: A complex developmental disorder characterized by mental retardation, delayed motor development, epilepsy, microcephaly and a wide spectrum of clinically heterogeneous features suggestive of neurocristopathies at the cephalic, cardiac, and vagal levels. Affected patients show an easily recognizable facial appearance with deep set eyes and hypertelorism, medially divergent, broad eyebrows, prominent columella, pointed chin and uplifted, notched ear lobes. Some patients manifest Hirschsprung disease. {ECO:0000269|PubMed:11448942, ECO:0000269|PubMed:12451214, ECO:0000269|PubMed:15384097, ECO:0000269|PubMed:16688751}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.223

Intolerance Scores

LoFtool
0.0187
RVIS EVS
-0.91
RVIS percentile EVS
10.03

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
S
Essential (gene trap)
K
Indispensability pred.
E
Indispensability score
0.960

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.